3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
32
Myelodysplastic Syndromes
28
Multiple Myeloma
27
Precursor Cell Lymphoblastic Leukemia-Lymphoma
26
Hodgkin Disease
12
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
11
Lymphoma, Non-Hodgkin
10
Lymphoma
10
Hematologic Neoplasms
10
Neuroblastoma
9
Myeloproliferative Disorders
9
Anemia, Refractory, with Excess of Blasts
8
Lymphoma, Mantle-Cell
7
Leukemia, Myelomonocytic, Chronic
7
Leukemia
7
Neoplasms, Plasma Cell
6
Lymphoma, T-Cell
6
Leukemia, Biphenotypic, Acute
6
Graft vs Host Disease
6
Leukemia, Lymphocytic, Chronic, B-Cell
5
Burkitt Lymphoma
5
Recurrence
4
Primary Myelofibrosis
4
Melanoma
4
Lymphoma, Large B-Cell, Diffuse
4
Lymphoma, Follicular
4
Leukemia, Myelomonocytic, Juvenile
4
Hematologic Diseases
4
Ganglioneuroblastoma
4
Anemia, Aplastic
4
Interventions
Nivolumab
3
capivasertib
2
Gemcitabine
2
Cisplatin
2
tivozanib
1
regorafenib
1
niraparib
1
neratinib
1
lutetium Lu 177 dotatate
1
fludarabine phosphate
1
fludarabine
1
encorafenib
1
durvalumab
1
copanlisib
1
cemiplimab
1
axicabtagene ciloleucel
1
avasopasem manganese
1
Valproic Acid
1
Thioctic Acid
1
Taxes
1
Receptors, Interleukin-6
1
Radiosurgery
1
RNA-Seq
1
Pemetrexed
1
Paclitaxel
1
Oxaliplatin
1
Multiparametric Magnetic Resonance Imaging
1
Leucovorin
1
Lenalidomide
1
Interleukin 1 Receptor Antagonist Protein
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Disease Progression
×
Melphalan
×
1 year
×
Clear all
No trials found.